Claris Lifesciences Ltd - CLARIS LIFESCIEN Share Price

Sector: Pharmaceuticals | ISIN: INE562G01018
₹ 396.55 (-0.06%) icon14 Mar, 2018, 3:29:01 PM

Claris Lifesciences Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/14/2018 3:29:01 PM

    ₹ 396.55 -0.25 -0.06
  • Open
  • ₹ 395.1
  • Prev. Close
  • ₹ 396.8
  • Turnover(Lac.)
  • ₹ 500
  • Day's High
  • ₹ 396.9
  • Day's Low
  • ₹ 395
  • 52 Week's High
  • ₹ 0
  • 52 Week's Low
  • ₹ 0
  • Book Value
  • ₹ -2.137
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 2,163.88
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Claris Lifesciences Ltd Corporate Actions

No Record Found


Claris Lifesciences Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Claris Lifesciences Ltd SHAREHOLDING SNAPSHOT
30 April , 2024 | 10:39 AM

PROMOTER - TOTAL50.13%

Indian: 50.13%

Foreign: 0%

NON-PROMOTER - TOTAL 49.87%

Institutions: 27.96%

Non-Institutions: 21.91%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Claris Lifesciences Ltd FINANCIALS

Claris Lifesciences Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Claris Lifesciences Ltd

  • SURRINDER LAL KAPUR
  • Director
  • ARJUN SUSHILKUMAR HANDA
  • Managing Director
  • CHANDRASINGH SHIVRAMBHAI PUROHIT
  • Whole-time Director
  • ANUP PRAVIN SHAH
  • Director
  • ADITYA SUSHILKUMAR HANDA
  • Director
  • KIRITKUMAR HIMATLAL KANJARIA
  • Company Secretary
  • SHYAMSUNDER KASHIRAM SHARMA
  • Director

Summary

Claris Lifesciences Ltd is one of the largest sterile injectables pharmaceutical companies in India with a market presence in 76 countries worldwide. The company primarily manufactures and markets products across multiple markets, and therapeutic segments. Their products offering comprise 128 products across multiple markets and therapeutic areas. All of their products are off-patent products, a significant majority of which are capable of being directly injected into the body and are predominantly used in the treatment of critical illnesses.The companys products range across various therapeutic segments includes anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral & parenteral nutrition and oncology. They offer injectables in various delivery systems, such as glass and plastic bottles, vials, ampoules, pre-filled syringes and non-PVC/PVC bags. Their customer base primarily includes government and private hospitals, aid agencies, and nursing homes.The company has five manufacturing facilities spread over a 78-acre campus located in Ahmedabad, India. Some of these facilities have been approved by foreign regulatory authorities including the USFDA, MHRA (UK), TGA (Australia), NAM (Finland), GCC FDCA (Gulf Co-operation Council including Saudi Arabia, U.A.E. and other countries in the Middle East), ANVISA (Brazil) and INVIMA (Colombia). The company has four subsidiaries in India and thirteen subsidiaries located in Brazil, the United States,... Read More


Reports by Claris Lifesciences Ltd


Reports by Claris Lifesciences Ltd

Company FAQ

No Record Found